23andMe Holding Co. (NASDAQ:ME - Get Free Report) insider Kathy L. Hibbs sold 38,548 shares of the business's stock in a transaction dated Thursday, April 4th. The shares were sold at an average price of $0.50, for a total transaction of $19,274.00. Following the completion of the transaction, the insider now owns 1,252,315 shares in the company, valued at $626,157.50. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.
23andMe Trading Up 1.7 %
Shares of ME stock opened at $0.48 on Friday. The firm's 50 day moving average is $0.59 and its 200-day moving average is $0.76. 23andMe Holding Co. has a 1 year low of $0.40 and a 1 year high of $2.32.
23andMe (NASDAQ:ME - Get Free Report) last posted its quarterly earnings results on Wednesday, February 7th. The company reported ($0.17) earnings per share for the quarter. The business had revenue of $44.75 million for the quarter, compared to the consensus estimate of $56.30 million. 23andMe had a negative return on equity of 52.99% and a negative net margin of 210.48%.
Institutional Investors Weigh In On 23andMe
Jeff Bezos Just Humiliated Elon Musk
From InvestorPlace | Ad
The Next Nvidia?
Wall Street legend has just uncovered one tiny Maryland company that could become the next Nvidia. Few in the media are talking about this story yet… but in the next 6 months that’s all they’ll talk about.
Go here now for this breaking story.
Large investors have recently bought and sold shares of the company. Ameriprise Financial Inc. bought a new stake in 23andMe in the first quarter valued at approximately $26,000. Walleye Capital LLC bought a new stake in 23andMe in the second quarter valued at approximately $28,000. Cornerstone Wealth Management LLC bought a new stake in shares of 23andMe during the first quarter worth $28,000. China Universal Asset Management Co. Ltd. increased its position in shares of 23andMe by 361.0% during the fourth quarter. China Universal Asset Management Co. Ltd. now owns 36,049 shares of the company's stock worth $33,000 after acquiring an additional 28,229 shares in the last quarter. Finally, Geneos Wealth Management Inc. bought a new stake in shares of 23andMe during the first quarter worth $34,000. Institutional investors own 36.10% of the company's stock.
About 23andMe
(
Get Free Report)
23andMe Holding Co operates as a consumer genetics testing company. The company operates in two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of passing on certain rare carrier conditions to their children, as well as reports on how genetics can impact responses to medications.
Read More
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
